We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 14.98%
2 Technology 14.23%
3 Financials 12.72%
4 Industrials 11.05%
5 Energy 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GIB icon
1326
CGI
GIB
$15.7B
$18K ﹤0.01%
500
-125,600
-100% -$4.24M
HTCH
1327
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
$17K ﹤0.01%
6,900
– –
CRD.A icon
1328
Crawford & Co Class A
CRD.A
$540M
$15K ﹤0.01%
1,861
– –
HYMB icon
1329
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.1B
$15K ﹤0.01%
+540
New +$15K
AUQ
1330
DELISTED
AURICO GOLD INC COM
AUQ
$15K ﹤0.01%
3,600
-14,200
-80% -$57.4K
FRF
1331
DELISTED
FORTEGRA FINL CORP COM STK (DE)
FRF
$15K ﹤0.01%
2,000
– –
BKYF
1332
DELISTED
BK KY FINL CORP
BKYF
$14K ﹤0.01%
400
– –
UFPI icon
1333
UFP Industries
UFPI
$4.97B
$13K ﹤0.01%
780
– –
ALR
1334
DELISTED
AlerisLife Inc
ALR
$11K ﹤0.01%
210
– –
ONE
1335
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
$11K ﹤0.01%
+2,800
New +$13.7K
PDS
1336
Precision Drilling
PDS
$949M
$10K ﹤0.01%
35
+20
+133% +$5.16K
FRS
1337
DELISTED
FRISCH'S RESTAURANTS INC
FRS
$10K ﹤0.01%
403
– –
IVR icon
1338
Invesco Mortgage Capital
IVR
$757M
$9K ﹤0.01%
50
– –
MFA
1339
MFA Financial
MFA
$931M
$9K ﹤0.01%
275
– –
PROV icon
1340
Provident Financial
PROV
$111M
$9K ﹤0.01%
600
– –
CENT icon
1341
Central Garden & Pet Co
CENT
$2.76B
$8K ﹤0.01%
1,099
– –
FCLF
1342
DELISTED
FIRST CLOVER LEAF FINANCIAL CORP COM STK
FCLF
$8K ﹤0.01%
779
– –
ARL icon
1343
American Realty Investors
ARL
$227M
$7K ﹤0.01%
1,004
– –
OSHC
1344
DELISTED
Ocean Shore Holding Co.
OSHC
$7K ﹤0.01%
471
– –
HBM icon
1345
Hudbay
HBM
$9.79B
$6K ﹤0.01%
+700
New +$6.13K
SWS
1346
DELISTED
SWS GROUP INC
SWS
$5K ﹤0.01%
700
– –
AGNC icon
1347
AGNC Investment
AGNC
$12.7B
$4K ﹤0.01%
160
– –
CCJ icon
1348
Cameco
CCJ
$36.8B
$4K ﹤0.01%
200
-38,300
-99% -$799K
THC icon
1349
Tenet Healthcare
THC
$22.1B
$3K ﹤0.01%
63
-6,600
-99% -$298K
KSPN
1350
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$3K ﹤0.01%
35
-65
-65% -$4.45K
52 53
54
55 56

Similar funds

PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.